Kala Bio to conduct 1-for-30 reverse stock split on Nov. 13, 2026
Kala Bio shareholders approved a reverse stock split effective November 13, 2026, converting each 30 shares of common stock into one share. This move is necessary to meet Nasdaq listing requirements.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed